Lombard Odier Asset Management (Europe)’s Pfizer PFE Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-34,589	Closed	-$1.27M	–	242
2023 Q2	$1.27M	Sell	34,589 -1,656	-5%	-$64.5K	0.06%	211
2023 Q1	$1.48M	Sell	36,245 -2,126	-6%	-$91.8K	0.07%	215
2022 Q4	$1.97M	Sell	38,371 -16,026	-29%	-$768K	0.08%	205
2022 Q3	$2.38M	Sell	54,397 -3,946	-7%	-$192K	0.12%	162
2022 Q2	$3.06M	Sell	58,343 -9,071	-13%	-$462K	0.15%	152
2022 Q1	$3.49M	Buy	67,414 +9,112	+16%	+$473K	0.13%	126
2021 Q4	$3.44M	Buy	+58,302	New	+$2.89M	0.15%	104
2021 Q2	–	Sell	-7,100	Closed	-$257K	–	213
2021 Q1	$257K	Sell	7,100 -47,300	-87%	-$1.68M	0.01%	209
2020 Q4	$2M	Buy	54,400 +1,127	+2%	+$41.3K	0.12%	108
2020 Q3	$1.85M	Hold	53,273	–	–	0.11%	91
2020 Q2	$1.65M	Buy	53,273 +1,024	+2%	+$34.8K	0.24%	85
2020 Q1	$1.62M	Sell	52,249 -10,325	-17%	-$352K	0.13%	96
2019 Q4	$2.33M	Hold	62,574	–	–	0.17%	83
2019 Q3	$2.13M	Hold	62,574	–	–	0.17%	85
2019 Q2	$2.57M	Hold	62,574	–	–	0.22%	74
2019 Q1	$2.52M	Hold	62,574	–	–	0.25%	66
2018 Q4	$2.59M	Hold	62,574	–	–	0.23%	69
2018 Q3	$2.62M	Hold	62,574	–	–	0.18%	85
2018 Q2	$2.15M	Buy	62,574 +1,095	+2%	+$37.4K	0.16%	87
2018 Q1	$2.07M	Sell	61,479 -7,549	-11%	-$260K	0.14%	80
2017 Q4	$2.37M	Sell	69,028 -2,245	-3%	-$76.5K	0.15%	77
2017 Q3	$2.41M	Sell	71,273 -3,538	-5%	-$114K	0.14%	68
2017 Q2	$2.38M	Hold	74,811	–	–	0.14%	65
2017 Q1	$2.43M	Sell	74,811 -7,049	-9%	-$222K	0.14%	61
2016 Q4	$2.52M	Hold	81,860	–	–	0.91%	19
2016 Q3	$2.63M	Hold	81,860	–	–	0.9%	20
2016 Q2	$2.73M	Buy	+81,860	New	+$2.61M	0.14%	57
2015 Q1	–	Sell	-124,583	Closed	-$3.68M	–	123
2014 Q4	$3.68M	Buy	+124,583	New	+$3.57M	0.8%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s PFE Position: Q3 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Pfizer (PFE) in Q3 2023, closing a stake of 34,589 shares — an estimated $1.27M sold.

Lombard Odier Asset Management (Europe) first reported a position in PFE in Q4 2014 and held it in 28 quarters. The position peaked at $3.68M in Q4 2014. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Lombard Odier Asset Management (Europe) reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 34,589 Pfizer shares in Q3 2023, an estimated $1.27M.
Lombard Odier Asset Management (Europe) first reported a position in Pfizer in Q4 2014 and held it in 28 quarters.
Lombard Odier Asset Management (Europe)'s Pfizer position peaked at $3.68M in Q4 2014.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q3 2023, filed 14 Nov 2023.